FDA, Regulations

Sanofi, after long research journey, wins FDA approval for rare disease drug

September 1, 2022

Via: Biopharma Dive

The approval comes after more than two decades of research and development by rare disease specialist Genzyme, which Sanofi bought in 2011 for $20.1 billion. Patients with ASMD suffer from a lack of an enzyme needed to break down a […]